Vanda Pharmaceuticals Inc (VNDA)
6.24
-0.26
(-4.00%)
USD |
NASDAQ |
Jun 14, 16:00
6.242
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Market Cap: 363.16M for June 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 14, 2024 | 363.16M |
| June 13, 2024 | 378.29M |
| June 12, 2024 | 344.53M |
| June 11, 2024 | 348.61M |
| June 10, 2024 | 348.03M |
| June 07, 2024 | 356.17M |
| June 06, 2024 | 364.90M |
| June 05, 2024 | 293.90M |
| June 04, 2024 | 292.74M |
| June 03, 2024 | 297.98M |
| May 31, 2024 | 297.39M |
| May 30, 2024 | 291.57M |
| May 29, 2024 | 286.34M |
| May 28, 2024 | 289.83M |
| May 24, 2024 | 304.38M |
| May 23, 2024 | 285.75M |
| May 22, 2024 | 299.14M |
| May 21, 2024 | 297.39M |
| May 20, 2024 | 306.70M |
| May 17, 2024 | 318.93M |
| May 16, 2024 | 324.75M |
| May 15, 2024 | 311.94M |
| May 14, 2024 | 298.56M |
| May 13, 2024 | 293.90M |
| May 10, 2024 | 293.32M |
| Date | Value |
|---|---|
| May 09, 2024 | 291.57M |
| May 08, 2024 | 311.94M |
| May 07, 2024 | 318.93M |
| May 06, 2024 | 281.68M |
| May 03, 2024 | 284.01M |
| May 02, 2024 | 272.37M |
| May 01, 2024 | 277.60M |
| April 30, 2024 | 277.02M |
| April 29, 2024 | 280.51M |
| April 26, 2024 | 268.87M |
| April 25, 2024 | 260.73M |
| April 24, 2024 | 265.38M |
| April 23, 2024 | 269.46M |
| April 22, 2024 | 279.35M |
| April 19, 2024 | 297.38M |
| April 18, 2024 | 289.24M |
| April 17, 2024 | 304.95M |
| April 16, 2024 | 235.70M |
| April 15, 2024 | 236.28M |
| April 12, 2024 | 239.77M |
| April 11, 2024 | 249.08M |
| April 10, 2024 | 249.08M |
| April 09, 2024 | 253.74M |
| April 08, 2024 | 262.47M |
| April 05, 2024 | 280.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
194.46M
Minimum
Nov 09 2023
1.197B
Maximum
Jun 30 2021
615.19M
Average
612.60M
Median
May 07 2020
Market Cap Benchmarks
| ADMA Biologics Inc | 2.464B |
| INVO Bioscience Inc | 3.923M |
| Johnson & Johnson | 350.27B |
| Ligand Pharmaceuticals Inc | 1.438B |
| Sage Therapeutics Inc | 722.18M |
Market Cap Related Metrics
| PS Ratio | 2.025 |
| Price to Book Value | 0.6676 |
| Price | 6.24 |
| Earnings Yield | -1.24% |